This meta-analysis evaluated the efficacy of topical beta-blockers for EGFR inhibitor-induced paronychia and PGLs.<h4>Method</h4>In accordance with the PRISMA 2020 guidelines, multiple databases were searched for relevant studies. The gene discussed is EGFR; the disease is paronychia.